CANCER IN REMISSION

This adverse event was reported 241 times

CANCER IN REMISSION is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 ROMIDEPSIN 2 0.0012
1 DOLUTEGRAVIR SODIUM AND RILPIVIRINE HYDROCHLORIDE 2 0.0011
2 AFATINIB 3 0.0005
3 DOLUTEGRAVIR SODIUM 3 0.0003
4 LANREOTIDE ACETATE 2 0.0003
5 AMLODIPINE AND ATORVASTATIN 1 0.0002
6 HUMAN IMMUNOGLOBULIN G 5 0.0002
7 ACALABRUTINIB 3 0.0002
8 AMOXICILLIN AND CLAVULANATE POTASSIUM 1 0.0002
9 MEPERIDINE HYDROCHLORIDE 2 0.0002
See all drugs enriched for association with CANCER IN REMISSION